AETAS PHARMA
AETAS Pharma is a pharmaceutical company that specializes in research and development and licensing. Since its establishment in May 2000, the company has been engaged in drug discovery research and development for substances that have the effect of improving cardiac function and renal function. Especially for the development of atrial fibrillation therapeutics in heart disease, it is a pipeline that has been vigorously promoted since its establishment, and there is no definitive therapeutic at present, and we are developing a developed formulation for patients who are suffering.
AETAS PHARMA
Industry:
Health Care Pharmaceutical Product Research
Founded:
2000-05-23
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.aetaspharma.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Euro Pound Sterling Japanese Yen Japanese Server Location
Similar Organizations
Epione Laboratories
Epione Laboratories is a pharmaceutical company that specializes in full range of services that includes research and development.
Thai Minh Pharmaceuticals
Thai Minh Pharmaceutical provides marketing, research, and development services.
URL Pharma, Inc.
URL Pharma is a pharmaceuticals company specializing in drug research and development services.
Yakuodo
Yakuodo is a pharmaceutical company that specializes in drug store chain management and dispensing pharmacy management.
Zenara
Zenara is a pharmaceutical company that specializes in research and development, manufacturing, and quality and compliance.
Current Employees Featured
Investors List
Nissay Capital
Nissay Capital investment in Venture Round - AETAS Pharma
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC)
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC) investment in Venture Round - AETAS Pharma
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC)
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC) investment in Venture Round - AETAS Pharma
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC)
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC) investment in Venture Round - AETAS Pharma
Official Site Inspections
http://www.aetaspharma.com
- Host name: aetaspharma.com
- IP address: 210.154.251.37
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "AETAS Pharma"
Company Profile - Aetas Pharma Inc.
Trade name: Aetas Pharma Inc. Head office: 1-7 Kanda Ogawamachi, Chiyoda-ku, Tokyo 101-0052. Date of establishment: May 23, 2000. Paid-in capital: 97.13 million yenSee details»
Aetas Pharma Inc.
News Release. 2023/11. Phase II clinical trials of M201-A injection for patients with heart failure and renal dysfunction were initiated in the first semester.See details»
株式会社アエタスファルマ / aetas pharma
ニュースリリース. 2023/11. 心不全患者を対象としたm201-a塩酸塩注射剤の医師主導による前期第Ⅱ相臨床試験が開始しました。See details»
AETAS Pharma - Crunchbase Company Profile & Funding
AETAS Pharma is a pharmaceutical company that specializes in research and development and licensing. Since its establishment in May 2000, the company has been engaged in drug discovery research and development for …See details»
AETAS Pharma Co., Ltd. - Drug pipelines, Patents, Clinical trials
Www.aetaspharma.com. Holding Company | 2000 | Tokyo-to, Japan | < 10 | www.aetaspharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Aetas Pharma Company Profile 2024: Valuation, Funding
Aetas Pharma General Information Description. Developer of cardiac and renal ailment drugs intended to better treat arrhythmias and overactive bladders. The company develops drugs …See details»
AETAS Pharma - Overview, News & Similar companies
Www.aetaspharma.com. Revenue <$5 Million. Industry Manufacturing General Manufacturing . Recent News & Media. No recent news or media. Overview ; Who is AETAS Pharma. AETAS …See details»
AETAS Pharma - Products, Competitors, Financials, Employees ...
About AETAS Pharma. AETAS Pharma focuses on the research and development of pharmaceuticals in the cardiovascular field. The company specializes in creating innovative …See details»
AETAS Pharma Co., Ltd.: Drug pipelines, Patents, Clinical trials
Aug 23, 2023 Explore AETAS Pharma Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, Technology Platform:Small molecule drug, Drug:JTV-519 ...See details»
Aetas Pharma - Company Profile - Tracxn
Sep 21, 2024 AETAS Pharma is developing therapies for treating heart and kidney diseases. The lead candidate of the company K201, which has a stabilizing effect on ryanodine …See details»
AETAS Pharma Co., Ltd. - Patsnap
Discovery Company profile page for AETAS Pharma Co., Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Business Strategy - Aetas Pharma Inc.
Business Strategy：A novel therapeutic agent for heart failure, atrial fibrillation and chronic kidney disease, ryanodine receptor 2 inhibitor, M201-ASee details»
AETAS Pharma Co., Ltd. - Golden
AETAS Pharma Co., Ltd. is a Tokyo-based company in the pharmaceutical industry.See details»
AETAS Pharma - Funding, Financials, Valuation & Investors
Organization. AETAS Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 4. Lead …See details»
AETAS Pharma - Contacts, Employees, Board Members
AETAS Pharma is a pharmaceutical company that specializes in research and development and licensing.See details»
AETAS Pharma Co., Ltd. (AETAS Pharma Co., Ltd.) - 药物管线_专利_ …
了解AETAS Pharma Co., Ltd. (AETAS Pharma Co., Ltd.)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验和2篇文献，技术平台:小分子化药，药物:JTV-519，AK-14，M …See details»
Company Philosophy - Aetas Pharma Inc.
Company Philosophy：A novel therapeutic agent for heart failure, atrial fibrillation and chronic kidney disease, ryanodine receptor 2 inhibitor, M201-ASee details»
AETAS Pharma CEO, Founder, Key Executive Team, Board of …
Explore {AETAS Pharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Fuso Gets Japan Rights to Heart Failure Drug from Tokyo Upstart
Apr 27, 2022 Fuso Pharmaceutical Industries said on April 26 that it has inked a license pact with Tokyo-based drug discovery startup Aetas Pharma, obtaining the exclusive rights to …See details»
Licensing/Contact Us - Aetas Pharma Inc.
(1)We will acquire personal information from customers within the scope of the purpose of use and manage it safely. (2)With the exception of cases in which the customer has given his/her …See details»